Quick Answer
Longevity Health Holdings, Inc. reported Earnings Per Share Diluted of $4.83 (loss) per share for the year ending 2025.
- Longevity Health Holdings, Inc. showed an increase of +66.8% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Longevity Health Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2022: $6.74 (loss) per share | Q1 2023: $1.91 (loss) per share | Q2 2023: $5.00 (loss) per share | Q3 2023: $0.62 (loss) per share | Q1 2024: $4.28 (loss) per share | Q2 2024: $4.78 (loss) per share | Q3 2024: $4.13 (loss) per share | Q1 2025: $1.52 (loss) per share | Q2 2025: $1.56 (loss) per share | Q3 2025: $0.83 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), Longevity Health Holdings, Inc.'s Earnings Per Share Diluted has grown by 11.7%.
- Historical annual values: Fiscal year 2025: $4.83 (loss) per share | Fiscal year 2024: $14.56 (loss) per share | Fiscal year 2023: $1.46 (loss) per share | Fiscal year 2022: $5.47 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: